Related Experiment Video
Updated: Jul 31, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
Published on: July 3, 2015
Morphine upregulates mu opioid receptors of human and monkey lymphocytes
S Suzuki1, T Miyagi, T K Chuang
1Department of Medical Pharmacology and Toxicology, University of California, Davis, California, 95616, USA.
Abstract:
Opioid receptors of subtypes delta, kappa, and mu similar to those found in brain cells have been identified in immune cells. The current study demonstrates by competitive polymerase chain reaction the treatment of human lymphocytic cells with morphine resulting in an increased amount of gene expression of mu opioid receptors. Antibodies against the MOR-1, the neuronal mu opioid receptor, were used in Western blot analysis of mu proteins and the results revealed a single band of approximately 50 kDa, the intensity of which was increased by morphine treatment. Similar results of mu opioid receptor activation were observed when monkey lymphocytes were treated with morphine. These studies suggest that in addition to causing an immune effect through communication with the neuroendocrine system, the psychoactive drug morphine may modulate immune functions by acting directly on the mu opioid receptors expressed on lymphocytes.
Insights
Morphine treatment increases mu opioid receptor gene expression in human and monkey lymphocytes. This suggests morphine directly modulates immune functions by activating these receptors on immune cells.
Area of Science:
- Immunology
- Neuroscience
- Pharmacology
Background:
- Opioid receptors (delta, kappa, mu) are found in brain cells and immune cells.
- Morphine is a psychoactive drug with known neuroendocrine effects on the immune system.
Purpose of the Study:
- To investigate if morphine directly modulates immune functions by acting on mu opioid receptors expressed on lymphocytes.
- To determine the effect of morphine on mu opioid receptor gene expression in human lymphocytic cells.
Main Methods:
- Competitive polymerase chain reaction (PCR) was used to measure gene expression.
- Western blot analysis with antibodies against the neuronal mu opioid receptor (MOR-1) was performed.
- Human and monkey lymphocytes were treated with morphine.
Main Results:
- Morphine treatment increased mu opioid receptor gene expression in human lymphocytes.
- Western blot analysis showed increased mu protein levels (approx. 50 kDa) in lymphocytes after morphine treatment.
- Similar mu opioid receptor activation was observed in monkey lymphocytes treated with morphine.
Conclusions:
- Morphine may directly modulate immune functions by activating mu opioid receptors on lymphocytes.
- This direct action on lymphocytes complements known indirect immune effects via the neuroendocrine system.
More Related Videos
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Cholinergic Receptors: Muscarinic
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Analgesia and Pain Management
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...